Nomura Asset Management CO LTD Arcellx, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$31.75 - $57.99 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$31.51 - $37.4 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023
BUY
$27.49 - $46.9 $0 - $0
0 New
0 $0
Q1 2023

Jan 10, 2025
BUY
$26.92 - $33.94 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023
BUY
$26.92 - $33.94 $0 - $0
0 New
0 $0
Q4 2022

Jan 10, 2025
BUY
$17.18 - $33.0 $0 - $0
0 New
0 $0
Q4 2022

Feb 14, 2023
BUY
$17.18 - $33.0 $0 - $0
0 New
0 $0

Others Institutions Holding ACLX

# of Institutions
204
Shares Held
44.1M
Call Options Held
2.23M
Put Options Held
907K
View Full List

About Arcellx, Inc.

ACLX Quotes by TradingView
  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $2.99B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email